Red blood cells as advanced drug delivery systems for antiviral nucleoside analogues.
Magnani
M
M
Istituto di Chimica Biologica G. Fornaini, Università degli Studi di Urbino, Italy.
Rossi
L
L
Casabianca
A
A
Fraternale
A
A
Schiavano
G
G
Brandi
G
G
Mannello
F
F
Piedimonte
G
G
D000818:Animals; D000998:Antiviral Agents / Q000008:administration & dosage* / Q000009:adverse effects; D003845:Deoxycytosine Nucleotides / Q000008:administration & dosage* / Q000009:adverse effects; D054306:Dideoxynucleotides; D004337:Drug Carriers; D016503:Drug Delivery Systems; D004355:Drug Stability; D004910:Erythrocyte Membrane; D015497:HIV-1 / Q000502:physiology; D006801:Humans; D007942:Leukemia, Experimental / Q000188:drug therapy; D008264:Macrophages / Q000187:drug effects; D051379:Mice; D008810:Mice, Inbred C57BL; D011355:Prodrugs / Q000008:administration & dosage* / Q000009:adverse effects; D014779:Virus Replication / Q000187:drug effects
D000998:Antiviral Agents; D003845:Deoxycytosine Nucleotides; D054306:Dideoxynucleotides; D004337:Drug Carriers; D011355:Prodrugs; C037406:2',3'-dideoxycytidine 5'-triphosphate